These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 8364256)
1. Cytoplasmic membrane cholesterol and doxorubicin cytotoxicity in drug-sensitive and multidrug-resistant human ovarian cancer cells. Mazzoni A; Trave F Oncol Res; 1993; 5(2):75-82. PubMed ID: 8364256 [TBL] [Abstract][Full Text] [Related]
2. Membrane gangliosides and immuno-mediated cytolysis in drug sensitive and treatment-induced multidrug resistant human ovarian cancer cells. Mazzoni A; Trave F; Fabbri M; Leto G; Ghidoni R Anticancer Res; 1991; 11(6):2181-5. PubMed ID: 1776860 [TBL] [Abstract][Full Text] [Related]
3. Effect of the tiapamil analog RO11-2933 on cellular sensitivity to antitumor drugs in sensitive and multidrug resistant human ovarian cancer cells. Mazzoni A; Trave F; Canti G; Franco P Anticancer Res; 1989; 9(2):367-71. PubMed ID: 2751261 [TBL] [Abstract][Full Text] [Related]
4. Reversal of "atypical"-multidrug resistance by recombinant human tumor necrosis factor in the human ovarian cancer cell line A2780-DX3. Cimoli G; Valenti M; Parodi S; Mazzoni A; De Sessa F; Conte P; Russo P Oncol Res; 1993; 5(8):311-23. PubMed ID: 8012063 [TBL] [Abstract][Full Text] [Related]
5. The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model. Horowitz NS; Hua J; Gibb RK; Mutch DG; Herzog TJ Gynecol Oncol; 2004 Jul; 94(1):67-73. PubMed ID: 15262121 [TBL] [Abstract][Full Text] [Related]
6. Sensitivity of drug-resistant human ovarian tumor cell lines to combined effects of tumor necrosis factor (TNF-alpha) and doxorubicin: failure of the combination to modulate the MDR phenotype. Safrit JT; Berek JS; Bonavida B Gynecol Oncol; 1993 Feb; 48(2):214-20. PubMed ID: 8428693 [TBL] [Abstract][Full Text] [Related]
7. [Establishment of adriamycin-resistant human ovarian carcinoma cell line and its mechanism of multidrug resistance]. Li PY; Lin C Yao Xue Xue Bao; 1995; 30(4):258-62. PubMed ID: 7660793 [TBL] [Abstract][Full Text] [Related]
8. Scanning electron microscopy of multidrug resistant cells in haematological and mammary malignancies. Galimberti S; Bianchi F; Bernardini N; Mattii L; Dolfi A; Lupetti M; Petrini M Cell Mol Biol (Noisy-le-grand); 1993 Jul; 39(5):543-51. PubMed ID: 8104068 [TBL] [Abstract][Full Text] [Related]
9. Novel phosphonium salts display in vitro and in vivo cytotoxic activity against human ovarian cancer cell lines. Manetta A; Gamboa G; Nasseri A; Podnos YD; Emma D; Dorion G; Rawlings L; Carpenter PM; Bustamante A; Patel J; Rideout D Gynecol Oncol; 1996 Feb; 60(2):203-12. PubMed ID: 8631539 [TBL] [Abstract][Full Text] [Related]
10. Sensitivity of multidrug-resistant MCF-7 cells to a transferrin-doxorubicin conjugate. Lemieux P; Pagé M Anticancer Res; 1994; 14(2A):397-403. PubMed ID: 8017839 [TBL] [Abstract][Full Text] [Related]
11. A rapid and sensitive flow cytometric method for the detection of multidrug-resistant cells. Herweijer H; van den Engh G; Nooter K Cytometry; 1989 Jul; 10(4):463-8. PubMed ID: 2766891 [TBL] [Abstract][Full Text] [Related]
12. Relationship between cytotoxicity, drug accumulation, DNA damage and repair of human ovarian cancer cells treated with doxorubicin: modulation by the tiapamil analog RO11-2933. Alaoui Jamali MA; Yin MB; Mazzoni A; Bankusli I; Rustum YM Cancer Chemother Pharmacol; 1989; 25(2):77-83. PubMed ID: 2598402 [TBL] [Abstract][Full Text] [Related]
13. Role of carrier ligand in platinum resistance of human carcinoma cell lines. Schmidt W; Chaney SG Cancer Res; 1993 Feb; 53(4):799-805. PubMed ID: 8428361 [TBL] [Abstract][Full Text] [Related]
14. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines. Henkels KM; Turchi JJ Cancer Res; 1999 Jul; 59(13):3077-83. PubMed ID: 10397248 [TBL] [Abstract][Full Text] [Related]
15. Reversal of adriamycin resistance by recombinant alpha-interferon in multidrug-resistant human colon carcinoma LoVo-doxorubicin cells. Scala S; Pacelli R; Iaffaioli RV; Normanno N; Pepe S; Frasci G; Genua G; Tsuruo T; Tagliaferri P; Bianco AR Cancer Res; 1991 Sep; 51(18):4898-902. PubMed ID: 1893380 [TBL] [Abstract][Full Text] [Related]
16. Ormaplatin sensitivity/resistance in human ovarian cancer cells made resistant to cisplatin. Parker RJ; Vionnet JA; Bostick-Bruton F; Reed E Cancer Res; 1993 Jan; 53(2):242-7. PubMed ID: 8417816 [TBL] [Abstract][Full Text] [Related]
17. Cellular pharmacology of liposomal cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum(II) in A2780/S and A2780/PDD cells. Han I; Ling YH; al-Baker S; Khokhar AR; Perez-Soler R Cancer Res; 1993 Oct; 53(20):4913-9. PubMed ID: 8402681 [TBL] [Abstract][Full Text] [Related]
18. DNA breakage, cytotoxicity, drug accumulation and retention in two human ovarian tumor cell lines AZ224 and AZ364 treated with adriamycin, modulated by verapamil. Delvaeye M; Verovski V; De Neve W; Storme G Anticancer Res; 1993; 13(5A):1533-8. PubMed ID: 8239532 [TBL] [Abstract][Full Text] [Related]
19. Modulation of vindesine and doxorubicin resistance in multidrug-resistant pleural mesothelioma cells by tumor necrosis factor-alpha. Licht T; Lübbert M; Martens C; Bross KJ; Fiebig HH; Mertelsmann R; Herrmann F Cytokines Mol Ther; 1995 Jun; 1(2):123-32. PubMed ID: 9384669 [TBL] [Abstract][Full Text] [Related]
20. Selenite cytotoxicity in drug resistant and nonresistant human ovarian tumor cells. Caffrey PB; Frenkel GD Cancer Res; 1992 Sep; 52(17):4812-6. PubMed ID: 1511444 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]